Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
Cage Bio, Inc. See All Filings	D/A	2025-04-29 18:54:48 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001782671 Filed Document 0001782671-25-000001 Exclusions or Exemptions 506b Accepted Date 2025-04-29 18:54:48 UTC Type of Offering D/A Industry Other Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Cage Bio, Inc. See All Filings	D	2024-05-01 19:28:17 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001782671 Filed Document 0001782671-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-05-01 19:28:17 UTC Type of Offering D Industry Other Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Cage Bio, Inc. See All Filings	D	2021-10-27 19:54:53 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001782671 Filed Document 0001782671-21-000002 Exclusions or Exemptions 506b Accepted Date 2021-10-27 19:54:53 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Cage Bio, Inc. See All Filings	D/A	2021-02-22 16:34:43 UTC
Amount To Be Raised $9,806,246 Associated Brokers / Dealers N/A CIK Number 0001782671 Filed Document 0001782671-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-02-22 16:34:43 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Cage Bio, Inc. See All Filings	D	2019-07-18 15:05:00 UTC
Amount To Be Raised $11,896,962 Associated Brokers / Dealers N/A CIK Number 0001782671 Filed Document 0001782671-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-07-18 15:05:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity